PRECISION OPTICS CORPORATION, INC. Proceeds from Sale of Productive Assets
PRECISION OPTICS CORPORATION, INC. (POCI) reported Proceeds from Sale of Productive Assets of $3.70 thousand for the 6-month period ending 2012-12-31, per its 10-Q/A filed 2013-02-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2013-02-15
- PRECISION OPTICS CORPORATION, INC. proceeds from sale of productive assets for the quarter ending 2012-12-31 was $1.76K.
- PRECISION OPTICS CORPORATION, INC. proceeds from sale of productive assets for the quarter ending 2012-09-30 was $1.94K, a 5.46% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. proceeds from sale of productive assets for the quarter ending 2012-06-30 was $769.00, a 75.06% decline year-over-year.
- PRECISION OPTICS CORPORATION, INC. proceeds from sale of productive assets for the quarter ending 2012-03-31 was $11.18K, a 286.62% increase year-over-year.
- PRECISION OPTICS CORPORATION, INC. proceeds from sale of productive assets for fiscal 2012 was $10.23K, a 71.57% decline from fiscal 2011.
- PRECISION OPTICS CORPORATION, INC. proceeds from sale of productive assets for fiscal 2011 was $35.97K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 6 month as first filed | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|---|
| 2012-12-31 | $1.76K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-02-15 | $3.70K 10-Q/A · filed 2013-02-15 | $4.47K derived: sum of 3 quarters · filed 2013-02-15 | $15.65K derived: sum of 4 quarters · filed 2013-02-15 | |
| 2012-09-30 | $1.94K 10-Q · filed 2012-11-14 | $2.71K derived: sum of 2 quarters · filed 2012-11-14 | $13.89K derived: sum of 3 quarters · filed 2012-11-14 | $10.11K derived: sum of 4 quarters · filed 2013-02-15 | |
| 2012-06-30 | $769.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $11.95K derived: sum of 2 quarters · filed 2012-10-26 | $8.18K derived: sum of 3 quarters · filed 2013-02-15 | $10.23K 10-K/A · filed 2012-10-26 | |
| 2012-03-31 | $11.18K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-05-15 | $7.41K derived: sum of 2 quarters · filed 2013-02-15 | $9.46K 10-Q · filed 2012-05-15 | $12.54K derived: sum of 4 quarters · filed 2013-02-15 | |
| 2011-12-31 | -$3.77K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-02-15 | -$1.72K 10-Q/A · filed 2013-02-15 | $2.15K 10-Q · filed 2012-02-14 | $1.36K derived: sum of 3 quarters · filed 2013-02-15 | $4.25K derived: sum of 4 quarters · filed 2013-02-15 |
| 2011-09-30 | $2.05K 10-Q · filed 2012-11-14 | $5.13K derived: sum of 2 quarters · filed 2012-11-14 | $8.03K derived: sum of 3 quarters · filed 2012-11-14 | $25.96K derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $3.08K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $5.98K derived: sum of 2 quarters · filed 2012-10-26 | $23.91K derived: sum of 3 quarters · filed 2012-10-26 | $35.97K 10-K/A · filed 2012-10-26 | |
| 2011-03-31 | $2.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $20.83K derived: sum of 2 quarters · filed 2012-05-15 | $32.88K 10-Q · filed 2012-05-15 | ||
| 2010-12-31 | $17.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | $29.99K 10-Q · filed 2012-02-14 | |||
| 2010-09-30 | $12.05K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |